Profile data is unavailable for this security.
About the company
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
- Revenue in USD (TTM)153.59bn
- Net income in USD-4.16bn
- Incorporated1979
- Employees49.50k
- LocationCardinal Health Inc7000 Cardinal PlDUBLIN 43017-1091United StatesUSA
- Phone+1 (614) 757-3033
- Fax+1 (614) 757-6000
- Websitehttps://www.cardinalhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10X Genomics Inc | 264.22m | -48.76m | 8.85bn | 584.00 | -- | 21.59 | -- | 33.50 | -0.5085 | -0.5085 | 2.76 | 4.17 | -- | -- | -- | 452,431.50 | -- | -- | -- | -- | 76.47 | -- | -18.45 | -- | 6.95 | -- | 0.00 | -- | 68.06 | -- | 72.22 | -- | -- | -- |
| PPD Inc | 4.14bn | 63.36m | 9.37bn | 23.00k | 145.92 | -- | 28.88 | 2.26 | 0.1842 | 0.1842 | 12.10 | -3.10 | -- | -- | -- | -- | -- | -- | -- | -- | 40.05 | -- | 1.42 | -- | -- | 1.46 | 1.31 | -- | 7.52 | -- | -43.25 | -- | -- | -- |
| Quidel Corporation | 561.58m | 88.31m | 9.54bn | 1.25k | 110.86 | 15.75 | 67.81 | 16.98 | 2.05 | 2.05 | 13.11 | 14.41 | 0.5998 | 3.46 | 6.55 | 449,260.00 | 9.43 | 3.70 | 11.20 | 4.28 | 61.41 | 60.10 | 15.73 | 6.91 | 1.67 | 9.52 | 0.0207 | 0.00 | 2.41 | 23.77 | -1.70 | -- | 19.36 | -- |
| BIO-TECHNE Corp | 754.52m | 186.91m | 10.29bn | 2.25k | 56.84 | 7.95 | 38.31 | 13.64 | 4.74 | 4.74 | 19.18 | 33.87 | 0.3898 | 2.65 | 6.00 | 335,343.10 | 9.66 | 7.11 | 10.19 | 7.52 | 66.02 | 67.01 | 24.77 | 16.62 | 3.74 | 8.33 | 0.2454 | 50.02 | 11.04 | 14.82 | 3.36 | -2.84 | 12.95 | 0.8001 |
| Horizon Therapeutics PLC | 1.38bn | 592.29m | 10.54bn | 1.19k | 19.49 | 4.81 | 12.60 | 7.66 | 2.83 | 2.83 | 7.00 | 11.48 | 0.3335 | 6.08 | 3.32 | 1,146,306.00 | 14.36 | -0.3444 | 17.52 | -0.4104 | 73.00 | 64.95 | 43.06 | -1.19 | 2.27 | 1.67 | 0.383 | -- | 7.66 | 34.35 | 856.24 | -- | 38.53 | -- |
| Neurocrine Biosciences, Inc. | 886.78m | 176.53m | 11.64bn | 700.00 | 68.26 | 16.61 | 63.10 | 13.13 | 1.84 | 1.84 | 9.21 | 7.55 | 0.7646 | 0.491 | 8.04 | 1,266,834.00 | 15.22 | -9.18 | 16.75 | -10.71 | 99.05 | -- | 19.91 | -21.90 | 6.75 | 6.19 | 0.3716 | -- | 74.65 | -- | 75.32 | -- | 55.69 | -- |
| Catalent Inc | 2.87bn | 109.80m | 11.84bn | 12.30k | 97.93 | 5.15 | 33.66 | 4.12 | 0.7428 | 0.7428 | 19.29 | 18.04 | 0.4964 | 6.82 | 4.36 | 233,528.50 | 2.38 | 3.69 | 2.72 | 4.22 | 31.51 | 31.81 | 4.79 | 6.47 | 1.55 | 2.05 | 0.5337 | 0.00 | 2.22 | 6.62 | 8.87 | 48.70 | 12.25 | -- |
| Sarepta Therapeutics Inc | 407.50m | -655.92m | 12.69bn | 743.00 | -- | 11.08 | -- | 31.15 | -8.83 | -8.83 | 5.45 | 14.69 | 0.1659 | 0.3644 | 5.18 | 548,446.80 | -26.71 | -34.31 | -29.36 | -38.86 | 85.98 | -- | -160.96 | -191.55 | 7.75 | -49.14 | 0.3754 | -- | 26.51 | 108.11 | -97.58 | -- | 18.51 | -- |
| EXACT Sciences Corporation | 1.06bn | -106.63m | 12.99bn | 4.11k | -- | 5.10 | -- | 12.23 | -0.7663 | -0.7663 | 7.77 | 16.98 | 0.3409 | 4.49 | 10.83 | 258,411.40 | -3.42 | -14.64 | -3.66 | -15.93 | 75.98 | 72.26 | -10.04 | -40.25 | 5.81 | -5.54 | 0.3775 | -- | 92.82 | 244.80 | 52.04 | -- | 70.67 | -- |
| Cardinal Health Inc | 153.59bn | -4.16bn | 15.12bn | 49.50k | -- | 12.57 | -- | 0.0985 | -14.04 | -14.04 | 519.75 | 4.12 | 3.75 | 11.53 | 18.18 | 3,102,748.00 | -10.14 | 2.60 | -24.91 | 6.02 | 4.53 | 5.16 | -2.71 | 0.7268 | 0.5286 | 7.55 | 0.8576 | 59.41 | 6.38 | 9.83 | 300.44 | 3.22 | 5.67 | 9.50 |
| Alnylam Pharmaceuticals, Inc. | 285.93m | -886.42m | 17.21bn | 1.32k | -- | 12.57 | -- | 60.18 | -8.03 | -8.03 | 2.59 | 11.93 | 0.1332 | 0.6982 | 5.23 | 216,124.00 | -41.29 | -35.69 | -46.58 | -39.36 | 87.75 | -- | -310.01 | -600.53 | 4.48 | -- | 0.00 | -- | 193.36 | 34.16 | -16.24 | -- | 32.78 | -- |
| AmerisourceBergen Corp. | 186.16bn | 1.58bn | 20.36bn | 22.00k | 13.18 | 5.67 | 10.06 | 0.1094 | 7.59 | 7.59 | 886.85 | 17.66 | 4.60 | 16.11 | 12.97 | 8,461,793.00 | 3.94 | 2.11 | 16.50 | 8.73 | 2.78 | 2.78 | 0.8552 | 0.4435 | 0.6253 | 15.64 | 0.528 | 43.62 | 6.94 | 8.48 | -21.75 | 23.77 | 3.24 | 11.22 |
Data as of Jul 03 2020. Currency figures normalised to Cardinal Health Inc's reporting currency: US Dollar USD
40.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2020 | 35.14m | 12.04% |
| SSgA Funds Management, Inc.as of 31 Mar 2020 | 20.00m | 6.85% |
| BlackRock Fund Advisorsas of 31 Mar 2020 | 15.71m | 5.38% |
| Macquarie Investment Management Business Trustas of 31 Mar 2020 | 13.70m | 4.69% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2020 | 8.31m | 2.85% |
| Mellon Investments Corp.as of 31 Mar 2020 | 5.70m | 1.95% |
| Geode Capital Management LLCas of 31 Mar 2020 | 5.02m | 1.72% |
| SunAmerica Asset Management LLCas of 31 Mar 2020 | 4.85m | 1.66% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2020 | 4.46m | 1.53% |
| American Century Investment Management, Inc.as of 31 Mar 2020 | 4.23m | 1.45% |
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
